In a separate dataset, in which an IL-17 receptor A (IL-17RA) antibody was used in the treatment of psoriasis, a significant reduction of the expression of IL-19, IL-24, and Ki-67 in psoriatic lesional skin was found, reducing their expression levels close to those of non-lesional skin after treatment (Figure 6B). The gene discussed is MKI67; the disease is psoriasis.